We found that FTO, as an adiposity and obesity-related gene and an adipose metabolism-related gene (Wang et al., 2015), was the most promising LHD-binding candidate and may play a regulatory role in PA-induced inflammation process (Figure 4A; Supplementary Table S3). The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.